Extensior 0.5mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Extensior 0.5mg Injection
contains Semaglutide 0.5mg per weekly dose, manufactured by Zydus. This is the first therapeutic maintenance dose in the Extensior semaglutide range, delivering meaningful weight reduction and glycaemic improvement in adults with obesity or type 2 diabetes. Zydus ensures pharmaceutical-grade manufacturing consistency and safe drug delivery at this critical maintenance threshold.
Benefits:
- Clinically meaningful weight reduction (~3–4%) and HbA1c improvement (~1.4%) at maintenance
- Well-tolerated by most patients who have completed the 4-week 0.25mg initiation phase
- Once-weekly injection with consistent pharmacokinetics for sustained metabolic benefit
- Established GLP-1 cardiovascular and renal protective effects begin at this dose
- Manufactured by Zydus — India's globally accredited pharmaceutical manufacturer
How It Works:
At 0.5mg, semaglutide achieves robust therapeutic GLP-1 receptor activation — suppressing hypothalamic appetite centres, extending post-meal satiety through gastric emptying delay, and augmenting pancreatic insulin output in a glucose-dependent manner. These mechanisms work synergistically to reduce body weight, lower blood glucose, and improve metabolic risk factors over months of treatment.
Dosage and Administration:
Inject 0.5mg subcutaneously once weekly after completing at least 4 weeks on the 0.25mg initiation dose. Administer into the abdomen, thigh, or outer upper arm. Rotate injection sites. This dose can be maintained long term or advanced to 1mg for greater glycaemic control.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, abdominal pain. Uncommon: headache, fatigue, hypoglycaemia (with concurrent insulin/sulphonylurea). Serious: pancreatitis, gallbladder disease.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Adjust concurrent glucose-lowering agents as needed. Ensure adequate hydration. Not recommended during pregnancy.
Extensior Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Popular strength option | 2–4 wks | Weekly | Current |
| 1mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Extensior 0.5mg Injection used for?
Extensior 0.5mg is the first therapeutic maintenance dose of injectable semaglutide by Zydus, prescribed for adults with type 2 diabetes or obesity after completing the 4-week 0.25mg initiation phase.
Q2: Can Extensior 0.5mg be a long-term maintenance dose?
Yes. The 0.5mg dose is a licensed maintenance level for type 2 diabetes and can be continued indefinitely if it provides adequate glycaemic and weight management benefit. Some patients advance to 1mg for greater effect.
Q3: How does Extensior 0.5mg compare to Ozempic 0.5mg?
Extensior 0.5mg contains the same semaglutide at the same therapeutic dose as Ozempic 0.5mg. As a Zydus-manufactured equivalent, it delivers the same clinical outcomes at a substantially lower cost.
Q4: What blood glucose improvements can I expect on Extensior 0.5mg?
Semaglutide 0.5mg typically reduces HbA1c by approximately 1.4% from baseline over 30 weeks in adults with type 2 diabetes, alongside meaningful reductions in fasting and post-meal blood glucose.
Q5: When should I advance from Extensior 0.5mg to 1mg?
Advance to 1mg after at least 4 weeks at 0.5mg if glycaemic or weight targets are not adequately met. Your prescriber will assess response and decide whether dose escalation is appropriate for your clinical situation.
Customer Reviews
Priya Sharma
India · 1 month ago
“Prompt response from the team and smooth ordering process. Medicine arrived in original sealed packaging as expected.”
FirstCare Clinic
Canada · 3 months ago
“Good value for bulk procurement orders. Communication was clear and the shipment arrived within the estimated timeframe.”
Dr. Maria Santos
Australia · 3 weeks ago
“Good quality product. Shipping was fast and handled with care. Would recommend for professional hospital procurement.”
Michael K.
USA · 2 months ago
“Fast international shipping and professional packaging. Product was exactly as described. Highly recommend this supplier.”
Dr. James Wilson
USA · 1 week ago
“Excellent product quality. Arrived well-packaged with proper cold chain maintained throughout transit. Will order again.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.